Previous studies of methylphenidate in epilepsy patients have suffered from small numbers and methodological issues, such as lack of blinding.
© lassede signen/Shutterstock.com
Lennox-Gastaut Syndrome: Cannabidiol Treatment
What was the impact of add-on cannabidiol treatment in patients aged 2-55 years experiencing drop seizures?
Interesting Neuro: New Drugs & TBI Recovery
March news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.
Refractory Epilepsy: Cannabinoid Challenges & Benefits
Experimental data suggesting benefits of cannabinoid comes from purified, standardized preparations that may not translate to real world practice.
Neuro News Roundup: Stroke Outcomes
Studies include stroke risk with epilepsy, genetic predisposition for ischemic stroke, and dysphagia screening in stroke patients.
Interesting Neuro: Tumor Tx and Stroke Recovery
March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.
Epilepsy, Syncope, or Both?
Common presentations between epilepsy and syncope complicate the differential diagnosis, making syncope the most frequent misdiagnosis in epilepsy.
Epilepsy Risk with Depression
Researchers evaluated several databases to determine whether or not depression has a causative role on epilepsy, or vice versa.
Pregnancy Outcomes with Pregabalin Use
In this Medical News Minute, Dr. Bobby Lazzara highlights possible birth defects resulting from women taking pregabalin during pregnancy.
Modeling Simulations to Predict AED Efficacy
Researchers used simulations to predict the outcomes of epilepsy patients with partial-onset seizures converting to Aptiom monotherapy (800 mg QD).
Potential Treatment for SRSE
Research leading up to the ongoing phase 3 trial of SAGE-547, a potential drug for super-refractory status epilepticus, was presented at AAN 2016.
Antiepileptic Drug Choice: Patient vs Neurologist
Do you and your patients with epilepsy agree on treatment decisions? A national survey compares AED attribute preferences of patients and neurologists.
Top 10 Neurology Apps
Ten general and disease-specific apps for neurologists include assessment scales, anatomical diagrams, and interactive clinical decision support.
By clicking Accept, you agree to become a member of the UBM Medica Community.